๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for IgA Nephropathy

A Study of SHR-2173 in Participants With Primary IgA Nephropathy NCT07354932Phase 22 sites๐Ÿ“ Guangzhou๐Ÿ“ Shanghai Guangdong Hengrui Pharmaceutical Co., Ltd ยท Tests: SHR-2173 injection, SHR-2173 injection, SHR-2173 injection, Placebo A Study of JADE101 in Participants With Immunoglobulin A Nephropathy NCT07541287Phase 220 sites๐Ÿ“ Chula Vista๐Ÿ“ Arvada๐Ÿ“ Denver Jade Biosciences, Inc. ยท Tests: JADE101 Correlation of Microbiome and Metabonomics With IgA Nephropathy NCT05190848n/a5 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Guangdong Provincial People's Hospital A Phase 1 Study of CLYM116 in Normal Healthy Volunteers NCT07248865Phase 11 site๐Ÿ“ Brisbane Climb Bio, Inc. ยท Tests: CLYM116, Placebo A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. NCT07203404EARLY Phase 11 site๐Ÿ“ Shanghai Nanjing Bioheng Biotech Co., Ltd. ยท Tests: RD06-05 CART Cell Injection IgA Nephropathy Biomarkers Evaluation Study (INTEREST) NCT02954419n/a1 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: No intervention China Kidney Patient Trials Network NCT05036850n/a1 site๐Ÿ“ Beijing George (Beijing) Clinical Research Co. Ltd. The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA) NCT04858724n/a1 site๐Ÿ“ Shanghai Ruijin Hospital Study of BHV-1400 in IgA Nephropathy NCT07054684Phase 115 sites๐Ÿ“ Farmington๐Ÿ“ Miami Lakes๐Ÿ“ Miami Lakes Biohaven Therapeutics Ltd. ยท Tests: BHV-1400 CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease NCT07305116Phase 11 site๐Ÿ“ Hangzhou The Children's Hospital of Zhejiang University School of Meโ€ฆ ยท Tests: UCAR T-cell IgA Nephropathy Registration Initiative of High Quality (INSIGHT) NCT03001947n/a1 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: No intervention A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US NCT06952426n/a1 site๐Ÿ“ Boston Novartis Pharmaceuticals ยท Tests: No intervention, Other treatment, Iptacopan, Atrasentan A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy NCT04557462Phase 3161 sites๐Ÿ“ Glendale๐Ÿ“ San Diego๐Ÿ“ San Dimas Novartis Pharmaceuticals ยท Tests: LNP023 Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis NCT07010250n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases NCT07614477Phase 22 sites๐Ÿ“ Beijing๐Ÿ“ Tianjin Everest Medicines (China) Co.,Ltd. ยท Tests: EVER001 A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy NCT07616700Phase 22 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Haisco Pharmaceutical Group Co., Ltd. ยท Tests: HSK39297 200mgQD, HSK39297 300mgQD Chinese Adults With Kidney Disease NCT07522099Phase 29 sites๐Ÿ“ Shenzhen๐Ÿ“ Guiyang๐Ÿ“ Zhengzhou ADARx Pharmaceuticals, Inc. ยท Tests: ADX-038, Telitacicept A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy NCT04663204Phase 26 sites๐Ÿ“ Cambridge๐Ÿ“ Salford๐Ÿ“ Edinburgh University of Leicester ยท Tests: Sparsentan A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy. NCT07375758Phase 1, Phase 21 site๐Ÿ“ Beijing Beijing Mabworks Biotech Co., Ltd. ยท Tests: MIL116, Matching Placebo RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN) NCT06926244n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease NCT07507201EARLY Phase 11 site๐Ÿ“ Hangzhou The Children's Hospital of Zhejiang University School of Meโ€ฆ ยท Tests: UCAR T-cell KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis NCT03929887n/a6 sites๐Ÿ“ Chuncheon๐Ÿ“ Daegu๐Ÿ“ Seoul Seoul National University Hospital ยท Tests: Kidney Biopsy Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy NCT07606352Phase 28 sites๐Ÿ“ Newcastle๐Ÿ“ Penrith๐Ÿ“ Sydney Sitala Bio LTD ยท Tests: STL303, STL303, Placebo capsule A Trial of HRS-5965 Capsule in Primary IgA Nephropathy NCT07014826Phase 31 site๐Ÿ“ Beijing Chengdu Suncadia Medicine Co., Ltd. ยท Tests: HRS-5965, Placebo Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN NCT06994845Phase 320 sites๐Ÿ“ Madera๐Ÿ“ Aurora๐Ÿ“ Gainesville Novartis Pharmaceuticals ยท Tests: iptacopan Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (โ‰ฅ18 Years) Primary IgA Nephropathy? NCT06676384Phase 412 sites๐Ÿ“ Nadiฤd๐Ÿ“ Mysuru๐Ÿ“ Udupi Christian Medical College, Vellore, India ยท Tests: Oral prednisolone and SoC, Gut-directed budesonide and SoC, Mycophenolate mofetil (MMF) and SoC, Hydroxychloroquine andโ€ฆ Raman Spectroscopy Diagnosis of Kidney Diseases NCT06760845n/a1 site๐Ÿ“ Jinan Zunsong Wang ยท Tests: Imaging Time To Assess the Efficacy and Safety of Utilizing Galactose-deficient IgA1 Biomarker Changes to Guide Pathogenic IgA-targeted Therapeutic Strategies NCT07822100NA1 site๐Ÿ“ Beijing Hong Zhang ยท Tests: Gd-IgA1 monitoring Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial NCT07056595NA1 site๐Ÿ“ Moscow Botkin Hospital ยท Tests: Finerenone A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy NCT07582133Phase 21 site๐Ÿ“ Beijing Chengdu Suncadia Medicine Co., Ltd. ยท Tests: HRS-5965 Capsules
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy